期刊文献+

COX-2抑制剂(NS-398)对结肠癌HT-29细胞体外侵袭力的作用及CD44v6、nm23-H1基因的调节 被引量:2

Effect of NS-398 on invasion of colon cancer HT-29 cells in vitro and its regulation by CD44v6 and nm23-H1 genes
暂未订购
导出
摘要 目的研究NS-398对结肠癌HT-29细胞体外侵袭力的作用及CD44v6、nm23-H1基因的调节。方法通过流式细胞仪检测COX-2和CD44v6的表达,MTT检测细胞活性,改良的Boyden小室法观察HT-29细胞侵袭重组基底膜的能力,RT-PCR观察nm23-H1mRNA的表达。结果HT-29细胞COX-2表达阳性,0.1、1.0、10μmol/L NS-398可显著抑制HT-29细胞侵袭重组基底膜的能力,且上述作用与NS-398的毒性作用无关。NS-398可下调CD44v6的表达,上调nm23-H1mRNA的表达。结论NS-398具有抑制结肠癌细胞HT-29体外侵袭力的作用,下调CD44v6的表达和上调nm23-H1mRNA的表达可能是其作用机制。 AIM: To study the anti - invasive effect of NS - 398 on colon cancer cell hne HT - 29 in vitro an its regulation by CD44v6 and nm23 - H1 genes. METHODS: Flow cytometry was used to detect the expression of COX - 2 and CD44v6 in HT - 29 cells. MTT was used for cell survival rate tests. The modified Boyden chamber model was used for quantitative invasion assay. RT - PCR was used to detect the expression of nm23 - H1 mRNA. RESULTS: Flow cytometry analysis showed that COX - 2 was positive in HT - 29 cells. NS - 398 had significant inhibitory effects on invasion of HT - 29 cells, which had no relation with its cytotoxicity. NS- 398 down - regulated the expression of CD44v6 and up - regulated the expression of nm23 - H1 mRNA. CONCLUSION: NS - 398 has an anti - invasive effect on HT - 29 cells in vitro. Down - regulation of CD44v6 and up - regulation of nm23 - H1 may be its underlying mechanisms.
出处 《中国病理生理杂志》 CAS CSCD 北大核心 2005年第11期2197-2200,共4页 Chinese Journal of Pathophysiology
关键词 HT-29细胞 NS-398 结肠肿瘤 侵袭 肿瘤 CD44V6 nm23-HI 前列腺内过氧化物合酶 HT- 29 cells NS - 398 Colonic neoplasms Invasiveness, neoplasm CD44v6 nm23 - H1 Prostaglandin - endoperoxide synthase
  • 相关文献

参考文献2

二级参考文献7

共引文献32

同被引文献19

  • 1Waskewich C,Blumenthal RD,Li H,et al.Celecoxib exhibits the greatest potency amongst cyclooxygenase (COX)inhibitors for growth inhibition of COX-2-negative hematopoietic and epithelial cell lines[J].Cancer Res,2002,2 (7):2029-2033.
  • 2Verstovsek S,Kantarjian H,Manshouri T,et al.Prognostic significance of cellular vascular endothelial growth factor expression in chronic phase chronic myeloid leukemia[J].Blood,2002,9 (6):2265-2267.
  • 3Aguayo A,Kantarjian H,Manshouri T,et al.Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes[J].Blood,2000,6 (6):2240-2245.
  • 4Legros L,Bourcier C,Jacquel A,et al.Imatinib mesylate (STI571) decreases the vascular endothelial growth factor plasma level in patients with chronic myeloid leukemia[J].Blood,2004,104(2):495 -501.
  • 5Majima M,Hayashi I,Muramatsu M,et al.Cyclo-oxygenase -2 enhances basic fibroblast growth factor-in duced angiogenesis through induction of vascular endothelial growth factor in rat sponge implants[J].Br J Pharmacol,2000,30(3):641 -649.
  • 6Giles FJ,Kantarjian HM,Bekele BN,et al.Bone marrow cyclooxygenase-2 levels are elevated in chronic-phase chronic myeloid leukaemia and are associated with reduced survival[J].Br J Haematol,2002,119(1):38 -45.
  • 7Gasparini G,Longo R,Sarmiento R,et al.Inhibitors of cyclo-oxygenase 2:a new class of anticancer agents?[J].Lancet Oncol,2003,4(10):605 -615.
  • 8Yao M,Lam EC,Kelly CR. Cyclooxygenase-2 selective inhibition with NS-398 suppresses proliferation and invasiveness and delays liver metastasis in colorectal cancer[J].British Journal of Cancer,2004,(03):712-719.
  • 9Barnett J,Chow J,Ives D. Purification,characterization and aelective inhibition of human prostaglandin G/H synthase 1 and 2 expressed in the baculovirus system[J].Biochimica Et Biophysica Acta,1994,(01):130-139.
  • 10Blechacz B,Gores GJ. Cholangiocarcinoma:advances in pathogenesis,dingnosis,and treatment[J].Hepatology,2008,(01):308-321.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部